Clinical Benefit of Avapritinib in Patients With KIT-Mutant Gastrointestinal Stromal Tumors
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Clinical Benefit of Avapritinib in KIT-Mutant Gastrointestinal Stromal Tumors: A Post Hoc Analysis of the Phase I NAVIGATOR and Phase I/II CS3007-001 Studies
Clin. Cancer Res 2023 Nov 30;[EPub Ahead of Print], MC Heinrich, X Zhang, RL Jones, S George, C Serrano, Y Deng, S Bauer, S Cai, X Wu, Y Zhou, K Tao, Z Zheng, J Zhang, Y Cui, H Cao, M Wang, J Hu, J Yang, J Li, L ShenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.